Activity and safety of temozolomide in advanced adrenocortical carcinoma patients.
Cosentini D, Badalamenti G, Grisanti S, Basile V, Rapa I, Cerri S, Spallanzani A, Perotti P, Musso E, Laganà M, Ferrari VD, Luppi G, Dalla Volta A, Incorvaia L, Sigala S, Russo A, Volante M, Terzolo M, Berruti A.
Cosentini D, et al.
Eur J Endocrinol. 2019 Dec;181(6):681-689. doi: 10.1530/EJE-19-0570.
Eur J Endocrinol. 2019.
PMID: 31639772